Product Added Successfully.Please click cart button to proceed
Uploaded Successfully
Thank you for choosing TimesMed Pharmacy
Our representatives will contact you as soon as possible. If you want to reach us immediately, please call 98 8455 5001
Monuript 200mg Capsule
PRODUCT DETAILS
About Monuript 200mg Capsule
MOLNUPIRAVIR belongs to a class of drugs called antiviral agents indicated for the mild to the moderate treatment of Covid-19. Coronavirus disease/Covid-19, also known as SARS-CoV-2 (Severe Acute Respiratory Syndrome Corona Virus 2), is an infectious disease caused by the coronavirus. Its symptoms include fever and cough and, in some cases, progressing to pneumonia and respiratory failure.
MOLNUPIRAVIR contains Molnupiravir, a protease inhibitor. It works by interfering with a protein known as protease, which is necessary for the virus-infected cells to generate new viruses. As a result, the resulting virus particles have faulty genetic material and can no longer reproduce. Thereby, MOLNUPIRAVIR lowers virus load in the body and helps treat the infection.
Take MOLNUPIRAVIR as prescribed. To treat your condition effectively, you are advised to take MOLNUPIRAVIR for as long as your doctor has prescribed it. In some cases, MOLNUPIRAVIR may cause nausea, vomiting, diarrhoea, headache, and dizziness. Most of these side effects do not require medical attention and resolve gradually over time. However, if the side effects persist or worsen, please consult a doctor.
Women of child-bearing potential must use effective contraception during the treatment and for 4days after the last dose. Please seek medical advice from the doctor before taking MOLNUPIRAVIR if you are pregnant. Breastfeeding should be discontinued during the treatment and for 4days after the last dose. MOLNUPIRAVIR may cause dizziness, so drive with caution. It is unknown whether consuming alcohol with MOLNUPIRAVIR is safe. However, it is best to avoid alcohol consumption as it may cause increased dizziness. Keep your healthcare professional updated on your medical condition and medications to rule out any interactions.
Uses of Monuript 200mg Capsule
Covid-19 or Coronavirus.
Medicinal Benefits of Monuript 200mg Capsule
MOLNUPIRAVIR is an experimental antiviral medication that lowers the risk of hospitalisation or death in patients with mild or moderate covid-19. MOLNUPIRAVIR is a potent protease inhibitor that interferes with a protein (protease) required by virus-infected cells to generate new viruses. As a result, MOLNUPIRAVIR helps reduce viral load in the body and aids in infection therapy.
Directions for Use
Swallow MOLNUPIRAVIR as a whole with a glass of water. Do not crush or chew the tablet. Based on your medical condition your doctor will decide the duration.
Side Effects of Monuript 200mg Capsule
- Nausea
- Vomiting
- Diarrhoea
- Headache
- Dizziness
Similar Drugs
For informational purposes only. Consult a doctor before taking any medicines.
In-Depth Precautions and Warning
Drug Warnings
Please do not take MOLNUPIRAVIR if you are allergic to any of its ingredients. Women of child-bearing potential must use effective contraception during the treatment and for 4days after the last dose. Please seek medical advice from the doctor before taking MOLNUPIRAVIR if you are pregnant. Breastfeeding should be discontinued during the treatment and for 4days after the last dose. MOLNUPIRAVIR may cause dizziness, so drive with caution. It is unknown whether consuming alcohol with MOLNUPIRAVIR is safe. However, it is best to avoid alcohol consumption as it may cause increased dizziness. Keep your doctor updated on your medical condition and medications to rule out any interactions.
Safety Advice
ALCOHOL
It is unknown whether it is safe to consume alcohol with MOLNUPIRAVIR. However, it is advisable not to take or limit alcohol as it may lead to increased dizziness.
PREGNANCY
MOLNUPIRAVIR is not recommended for use during pregnancy. Please seek medical advice if you are pregnant or intend to get pregnant. Women of child-bearing potential must use effective contraception during the treatment and for 4days after the last dose.
BREAST FEEDING
MOLNUPIRAVIR is not recommended during breastfeeding. Breastfeeding should be discontinued during the treatment and for 4days after the last dose.
DRIVING
MOLNUPIRAVIR may cause dizziness. So, drive only if you are alert.
LIVER
Limited information is available regarding the usage of MOLNUPIRAVIR in patients suffering from liver impairment. Please consult your doctor if you have any concerns.
KIDNEY
Limited information is available regarding the usage of MOLNUPIRAVIR in patients suffering from kidney impairment. Please consult your doctor if you have any concerns.